Newsy's Latest Health News

Pfizer has requested the FDA to extend emergency use authorization of its COVID-19 vaccine to children aged 12 to 15, citing a clinical trial that showed 100% effectiveness in this age group. This would make it the only vaccine available for younger teenagers. Health experts emphasize the importance of vaccinating children to achieve herd immunity. Additionally, Regeneron is seeking FDA approval to expand its antibody therapy, initially used to treat mild to moderate COVID-19 symptoms, as a preventative measure. Tests indicate it reduces the risk of symptomatic infections by 81% in people living with COVID-19 patients.

What age group is Pfizer seeking to expand emergency use authorization for its coronavirus vaccine?

What did Pfizer's clinical trial find regarding the vaccine's effectiveness in the 12 to 15 age group?

Why do health experts believe children need to receive COVID-19 vaccinations?

What percentage did the tests show the antibody cocktail reduces the risk of contracting symptomatic infections?

What is the purpose of Regeneron's request to the FDA regarding antibody therapy?